Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.
Gilead Sciences ( NASDAQ: GILD) is scheduled to announce Q4 earnings results on Tuesday, February 11th, after market close. Analysts expect a profit of $1.70 per share (-1.2% Y/Y) on revenue of $7.15B ...
Hosted on MSN11h
Gilead Sciences (GILD) Q4 Earnings: What To ExpectBiopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what ...
Tesla stock was heading for a fourth day of losses in early trading Monday after the Super Bowl. Tesla didn’t make a an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results